ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 161 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $47,000 | +88.0% | 599 | +49.8% | 0.01% | +85.7% |
| Q2 2019 | $25,000 | +150.0% | 400 | +100.0% | 0.01% | +250.0% |
| Q1 2018 | $10,000 | -96.5% | 200 | -96.2% | 0.00% | -96.8% |
| Q3 2017 | $282,000 | -30.2% | 5,300 | -18.5% | 0.06% | +5.1% |
| Q2 2017 | $404,000 | -42.7% | 6,500 | -37.5% | 0.06% | -27.2% |
| Q1 2017 | $705,000 | +169.1% | 10,400 | +181.1% | 0.08% | +138.2% |
| Q3 2016 | $262,000 | -56.1% | 3,700 | -69.7% | 0.03% | -59.0% |
| Q2 2016 | $597,000 | +108.7% | 12,200 | +378.2% | 0.08% | +130.6% |
| Q4 2015 | $286,000 | -67.2% | 2,551 | -71.8% | 0.04% | -64.0% |
| Q3 2015 | $872,000 | – | 9,051 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |